文献速递皮肤肿瘤

早期蕈样肉芽肿PUVA光疗维持期的循证评价

Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. A critically appraised topic.
PubMed 文献 · Br J Dermatol · 2017-01-01

本文为 critically appraised topic,评估早期蕈样肉芽肿患者PUVA诱导完全缓解后维持期是否降低复发率或延长无复发生存。检索Embase、PubMed和TRIP后纳入3篇文献,均为低证据级别,仅1项前瞻性研究、无随机对照。未发现维持期较单纯随访显著降低复发率或延长无复发生存,需随机对照试验验证。

要点

  • 早期MF患者PUVA达CR后,维持期较单纯随访未显著降低复发率或延长RFI。
  • 现有证据级别低,仅1项前瞻性研究,无随机对照试验。
  • USCLC指南建议维持期逐渐减少PUVA频率至临床复发,但缺乏高质量证据支持。

核心结论

  • 早期蕈样肉芽肿患者PUVA诱导完全缓解后,维持期较单纯随访未显著降低复发率或延长无复发生存。
  • 现有文献证据级别低,不足以将维持期作为早期MF的标准治疗方案。

研究设计与样本

  • 本文为critically appraised topic,检索Embase、PubMed和TRIP数据库(2016年6月),检索词为「mycosis fungoides」AND[(「photochemotherapy」OR「puva」)OR「psoralen」]。
  • 纳入3篇符合标准文献,仅1项为前瞻性研究,无随机对照试验。

主要发现

  • 与单纯随访相比,接受PUVA维持期患者在复发率降低或无复发生存延长方面无显著差异。
  • 所纳入研究中仅1项为前瞻性设计,其余非随机,整体证据级别低。

关键数值与推荐

  • USCLC指南建议对PUVA达完全缓解的早期MF患者维持治疗,定义为临床缓解期间逐渐降低紫外线频率直至停药。
  • USCLC指南还建议维持期采用标准化方案。

临床怎么用

  • 早期MF患者PUVA达CR后,维持期较单纯随访未显示显著获益,临床决策需个体化。
  • 现有证据不足以支持将维持期作为早期MF的标准治疗方案。

局限性

  • 文献数量少,证据级别低,仅1项前瞻性研究,无随机对照试验。
  • 缺乏随机对照试验比较维持期与不治疗,结论受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 65-year-old patient affected by mycosis fungoides (MF) stage IB achieved complete remission (CR) after a cycle of PUVA phototherapy. The U.S. Cutaneous Lymphoma Consortium (USCLC) guidelines suggest that the patient should be kept in the maintenance phase, defined as a 'period of gradual decrease of frequency of UVL [ultraviolet light] while in clinical remission before discontinuation of phototherapy' by slowly tapering the number of psoralen-ultraviolet A (PUVA) applications over time up to clinical relapse. The USCLC guidelines also suggest a standardized schedule for the maintenance phase. Alternatively, the patient could end PUVA therapy and go straight to follow-up. The aim of this critically appraised topic (CAT) was to determine if a maintenance phase gives a significant benefit in terms of relapse rate (RR) and RFI in patients affected by early-stage MF who had achieved CR under PUVA phototherapy. Embase, PubMed and TRIP databases were searched for 'mycosis fungoides' AND [('photochemotherapy' OR 'puva') OR 'psoralen'] in June 2016. Three articles matched our inclusion criteria and are discussed in this CAT. In this field of research the literature is poor and the reported level of evidence is low. Only one of the studies was conducted prospectively, and none were randomized. No significant difference in terms of reduction in relapse rate or increase in RFI in patients who underwent a PUVA maintenance phase emerged when compared with those who went for simple follow-up. Further randomized clinical trials (RCTs) are required in order to evaluate maintenance phase vs. no treatment before it can be favoured as the standard protocol of treatment in early-stage MF. At the time of writing this paper, we report an ongoing Austrian multicentre RCT (Clinical Trial.gov identifier: NCT01686594) that will hopefully give useful results in this topic.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Grandi V, Delfino C, Pileri A, et al. Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. A critically appraised topic. Br J Dermatol. 2017. PMID: 28078669. doi:10.1111/bjd.15302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。